Medical News

RSS

Enrollment complete in Nabi's first NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the first Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational vaccine being developed to treat nicotine addiction and prevent smoking relapse.

15 Jul 2010

U.S. taxpayers spend equal amounts on non-emergency food aid and shipping, study says

IRIN examines the findings of a study about the costs and effects of the U.S. Agricultural Cargo Preference policy, noting that "U.S. taxpayers spend about $140 million every year on non-emergency food aid in Africa, and roughly the same amount to ship food aid to global destinations on U.S. vessels; money that could have been used to feed more people."

15 Jul 2010

Mylan subsidiary receives FDA final approval for Nabumetone Tablets ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nabumetone Tablets USP, 500 mg and 750 mg.

15 Jul 2010

KRX-0401 receives Orphan Drug designation from FDA for treatment of neuroblastoma

Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of neuroblastoma, a cancer of the nervous system affecting mostly children and infants for which there are no FDA approved therapies.

15 Jul 2010

Iovate Health Sciences reaches agreed settlement with Federal Trade Commission on advertising

Iovate Health Sciences is pleased to have reached an agreed settlement with the Federal Trade Commission involving advertising for certain products. These products -- Cold MD, Germ MD, Allergy MD, Accelis, and nanoSlim -- have long been discontinued, some as far back as 2007.

15 Jul 2010

Mylan to acquire Bioniche Pharma for $550M

Mylan Inc. today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan's earnings in year one, without accounting for any operational or other synergies.

15 Jul 2010

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

UNAIDS on Tuesday outlined a new strategy, called "Treatment 2.0," to simplify the provision of HIV treatment and improve global access to antiretrovirals, Reuters reports. The agency says the plan could prevent up to 10 million AIDS-related deaths by 2025 and reduce the number of new HIV infections annually by up to one million, if all people in need receive treatment, according to the news service.

15 Jul 2010

AP further examines how PEPFAR helped inform new U.S. domestic HIV/AIDS strategy

"The national strategy for combatting HIV and AIDS the Obama administration released Tuesday credits the Bush-era international campaign against AIDS for setting clear targets and ensuring a variety of agencies and groups worked together smoothly to achieve them," the Associated Press writes in a piece that examines how PEPFAR served to inform the national strategy.

15 Jul 2010

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest and Tamoxitest. These tests and the GeneMedRx medication management software can save lives and healthcare dollars by allowing doctors to personalize their prescribing practices in order to prevent adverse medication outcomes, including treatment failures and dangerous side effects.

15 Jul 2010

Gilead sues Lupin over Ranexa patent infringement

Gilead Sciences, Inc. today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa® (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.

15 Jul 2010

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

The leukemia stem cell-the root cause of all acute leukemias- represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease.

15 Jul 2010

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009.

15 Jul 2010

Support for health overhaul down; GOP asks Kagan if she would recuse herself from cases on new law

Support for the new health reform law has dropped seven percentage points in the last two months, though it remains higher than when the law was first signed in March. "Forty-nine percent of Americans now disapprove of the health care reform measure, according to the poll, which was conducted July 9-12. Thirty-six percent support the law. In a May CBS News poll, 47 percent disapproved of the new laws, while 43 percent approved. While the new poll shows a recent drop in support, the numbers have still improved overall since March, when 53 percent of Americans disapproved of the new laws and 32 percent said they approved of them."

15 Jul 2010

HHS relaxes some rules for doctors, hospitals to get aid for electronic health records

Kaiser Health News staff writer Phil Galewitz reports: "The federal government is making it easier for health care providers to get bonus money for using electronic health records starting next year, but the hospital industry said it still had concerns that too few facilities would qualify"

15 Jul 2010

Research: Early diagnosis, care management for people with dementia can lower outpatient costs by 30%

Early detection, diagnosis and care management for people newly diagnosed with cognitive impairment and dementia reduces outpatient costs by almost 30 percent, according to new research reported today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu.

15 Jul 2010

EpiCept increases exercise price of June 2010 Warrants to $1.64 per share

EpiCept Corporation has amended the exercise price of its Series A Warrants and Series B Warrants sold in June 2010 from $1.57 per share to $1.64 per share. The exercise price was amended by Amendment No.1 dated as of July 8, 2010, to the Securities Purchase Agreement between EpiCept and each of the purchasers signatory thereto, which amended the Securities Purchase Agreement dated June 25, 2010 between EpiCept and each of the purchasers signatory thereto.

15 Jul 2010

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.

15 Jul 2010

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

Northeast Florida's Medicaid recipients are making fewer trips to the doctor for chronic illnesses since state officials outsourced the government-subsidized health insurance program to private managed care companies. But it remains unclear from the analysis performed by the Florida Agency for Health Care Administration, which oversees the state's Medicaid program, whether they're healthier for it. Medicaid reform was launched in 2006 in Duval and Broward counties to test whether HMOs could rein in the state's Medicaid spending.

15 Jul 2010

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

The University of Michigan Hospitals and Health Centers have been ranked among the country's best hospitals, placing 14th overall for the second consecutive year by U.S. News & World Report magazine. This year, U-M was ranked in every specialty and those rankings went up in 11 of the 16 specialties.

15 Jul 2010

Absorption Systems' GLP facility receives full accreditation from AAALAC

Absorption Systems, a leader in testing drugs for ADMET, announced today that its GLP facility in San Diego, Calif., for preclinical testing of drugs, biologics and medical devices received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International.

15 Jul 2010

Medical News

Enrollment complete in Nabi's first NicVAX Phase III clinical trial for nicotine addiction

U.S. taxpayers spend equal amounts on non-emergency food aid and shipping, study says

Mylan subsidiary receives FDA final approval for Nabumetone Tablets ANDA

KRX-0401 receives Orphan Drug designation from FDA for treatment of neuroblastoma

Iovate Health Sciences reaches agreed settlement with Federal Trade Commission on advertising

Mylan to acquire Bioniche Pharma for $550M

New HIV treatment strategy could reduce HIV-related deaths by 10M in 15 years, UNAIDS says

AP further examines how PEPFAR helped inform new U.S. domestic HIV/AIDS strategy

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

Gilead sues Lupin over Ranexa patent infringement

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.

Support for health overhaul down; GOP asks Kagan if she would recuse herself from cases on new law

HHS relaxes some rules for doctors, hospitals to get aid for electronic health records

Research: Early diagnosis, care management for people with dementia can lower outpatient costs by 30%

EpiCept increases exercise price of June 2010 Warrants to $1.64 per share

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

Florida Medicaid recipients make fewer trips to doctors; Calif. payments to health clinics in jeopardy; Texas addresses nursing shortage

U-M Hospitals and Health Centers ranked 14th among America's best hospitals

Absorption Systems' GLP facility receives full accreditation from AAALAC

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News